Molnupiravir to treat COVID-19: Digemid authorizes drug marketing
The General Directorate of Medicines, Supplies and Drugs (Digemid) granted the Conditional Sanitary Registration to Molnupiravir, drug developed by the company Merck Sharp & Dohme (MSD), for sale in the country with